Consider MicroStrategy (MSTR) as a leveraged investment in Bitcoin, as the company is viewed as one of the most interesting plays in the current market. The strategy of issuing MSTR stock at a premium to aggressively acquire more BTC is seen as highly beneficial for long-term shareholders. With the highest options open interest in the market, MSTR is a focal point for traders and could experience significant volatility. Another potential opportunity is an asset referred to as STRC, which is seen as racing back towards a $100 price target. An upcoming ex-dividend date for STRC could act as a near-term positive catalyst for its price.

Bitcoin (BTC)

• The speaker notes the current price is a "meme-worthy $69,000".
• He finds it "fishy" that MicroStrategy's recent purchase was at an average price of $78,800, significantly higher than the current market price.
• He speculates that it may not be possible to buy meaningful quantities of Bitcoin at the prices advertised on exchanges, suggesting a potential supply shortage or hidden costs for large-scale buyers.
• The speaker believes Bitcoin is currently "still in a bear market" and needs to rebound.
• He is dismissive of online predictions that the bear market will last another four to six months, stating that "nobody knows" the short-term direction of the price.

Takeaways

• The actual cost for large institutional buyers of Bitcoin may be much higher than the spot price quoted on exchanges. This could imply strong underlying demand and a tightening supply.
• The short-term outlook for Bitcoin is highly uncertain. While the speaker personally feels it's in a bear market, he advises that nobody can predict the immediate future with any certainty.

MicroStrategy (MSTR)

• MicroStrategy continues its aggressive Bitcoin acquisition strategy, having just bought another $90 million worth of BTC.
• The purchase was funded by issuing new common stock through an At-The-Market (ATM) offering.
• The speaker is very bullish on this strategy, especially when MSTR's stock trades at a significant premium to its underlying Bitcoin assets. He celebrates the recent stock issuance at a 1.19x premium ("selling a dollar for $1.19") and wishes it was even higher.
• He believes that short-term traders ("tourists") have left the stock, and the current shareholder base consists of long-term believers who intend to hold into the 2030s.
• MSTR has the highest open interest in the options market, surpassing even mega-cap stocks like NVIDIA (NVDA), Meta (META), and Tesla (TSLA). The speaker views this as a sign that MSTR "may be the most interesting play" in the market.

Takeaways

• MSTR is presented as a leveraged investment vehicle for Bitcoin. The company's strategy of issuing stock at a premium to acquire more Bitcoin is considered beneficial for long-term shareholders.
• The high level of options activity indicates significant trader interest, which could lead to heightened volatility but also provides liquidity for those looking to trade around a Bitcoin-related thesis.
• The stock is best suited for investors with a long-term bullish outlook on Bitcoin who are comfortable with the company's corporate strategy.

STRC / "Stretch"

• The podcast episode title refers to "STRC Racing Back to $100!", while the speaker refers to the asset as "stretch".
• The speaker is bullish, noting the price is rebounding and is "almost at $99.50", a level he expected it to reach later in the week.
• He states that "People are seeing the value of stretch."
• A potential upcoming catalyst mentioned is an ex-dividend date.

Takeaways

• The speaker is bullish on an asset, possibly with the ticker STRC, that is trading near $100.
• An upcoming dividend may act as a positive short-term catalyst for the price.
• Important Note for Investors: There is significant ambiguity regarding this asset. The ticker STRC (Sarcos Technology and Robotics Corp.) does not trade near the $99.50 price mentioned, nor does it currently pay a dividend. The information is presented as stated in the podcast, but investors should perform their own due diligence to identify the correct asset before making any investment decisions.

Hims & Hers Health (HIMS)

• The stock was mentioned briefly as a company that was being discussed on CNBC.
• The speaker strongly disagreed with CNBC's analysis, calling it an "epically bad take".
• He states that he is creating a separate, dedicated video about HIMS.

Takeaways

• The speaker has a contrarian view on HIMS compared to the mainstream financial media.
• While he doesn't state his position, the negative commentary on CNBC's "bad take" implies he may be bullish on the stock. Investors interested in this name should look for his follow-up content to understand his full thesis.